Peter Weber
Neurological Surgery · San Francisco, CANPI 1639165483
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (35.8%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Neuropace, Inc. at 29.1% of the total. Reporting peaked in 2020 at $7,421 and has fallen 99.6% since, to $32 in 2025.
Across 115 payments — averaging $132.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$4K
- Globus Medical$4K
- Spine Wave, Inc.$3K
- Zimmer Biomet$2K
- UCB, Inc.$305
- SK Life Science, Inc.$288
- plus $1K from 21 others
Across 7 payments — averaging $21,223 each. An ownership or investment interest held by the physician or an immediate family member.
- Providence Medical Technology, Inc.$149K
What the payments were for
- Royalty or licence$3,00420%
- Consulting fees$3,90026%
- Travel & lodging$5,45036%
- Food & beverage$2,88219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 10 | $4,435 |
| Globus Medical | 8 | $3,615 |
| Spine Wave, Inc. | 20 | $3,004 |
| Zimmer Biomet | 14 | $2,170 |
| UCB, Inc. | 8 | $305 |
| SK Life Science, Inc. | 3 | $288 |
| Johnson & Johnson | 2 | $208 |
| Medtronic(2 entities) | 8 | $177 |
| Greenwich Biosciences, Inc. | 4 | $160 |
| Eisai Inc. | 6 | $150 |
| Sunovion Pharmaceuticals Inc. | 11 | $138 |
| Jazz Pharmaceuticals Inc. | 1 | $136 |
| Novartis | 3 | $63 |
| Livanova USA, Inc. | 3 | $60 |
| Centinel Spine, LLC | 1 | $53 |
| Amgen | 2 | $47 |
| Monteris Medical Corporation | 1 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Adamas Pharmaceuticals, Inc. | 1 | $25 |
| Aquestive Therapeutics, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS System$3,900
- ExcelsiusGPS Robotic Navigation System$3,454
- Mobi-C$1,397
- Spinal Implants$1,033
- RNS Neurostimulator Kit$234
- Vitality$213
- XCOPRI$179
- Timberline$177
- Epidiolex$136
- Nayzilam$125
- VIPER$120
How this compares
$15,236 in reported general payments places this provider in the 70th percentile of 773 neurological surgery providers in California.
Other neurological surgery in San Francisco
- Christopher AmesSan Francisco$7.1M
- Praveen MummaneniSan Francisco$1.1M
- Lee TanSan Francisco$682K
- Jang YoonSan Francisco$227K
- Larry KhooLos Angeles$2.8M
- Samy AbdouSan Diego$2.4M
- Bret AbshireMurrieta$2.3M
- William TaylorSan Diego$2.1M
- Tooraj GravoriEncino$2M
- Ali MesiwalaRancho Cucamonga$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.